Table 2.
Hospital Test and Measurement of Patients With Versus Without MI
| Variables | No. of people used in the actual analysis | Total | With medical history of MI | Without medical history of MI | ASD/HL estimator |
|---|---|---|---|---|---|
| Low‐density lipoprotein, mmol/L | 885 351 | 2.8±1.2 | 2.7±1.2 | 2.8±1.2 | 8.3 |
| Total cholesterol, mg/dL | 211 534 | 36.6±71.3 | 33.7±66.8 | 36.6±71.4 | 4.2 |
| Triglyceride, mg/dL | 211 625 | 30.9±81.0 | 26.9±69.7 | 31.0±81.2 | 5.4 |
| Hemoglobin A1C, % | 795 866 | 6.3±1.8 | 6.4±1.8 | 6.3±1.8 | 5.6 |
| Fasting glucose, mmol/L | 884 263 | 6.4±2.9 | 6.6±3.0 | 6.4±2.9 | 6.8 |
| Homocysteine, mmol/L | 797 766 | 14.4±7.4 | 14.7±7.6 | 14.3±7.4 | 5.3 |
| Serum creatinine, µmol/L | 888 198 | 128.2±1211.9 | 103.8±881.5 | 130.7±1240.2 | 2.5 |
| BUN, mmol/L | 886 332 | 5.7±2.4 | 6.0±2.6 | 5.7±2.4 | 12.0 |
| INR | 878 615 | 1.2±0.9 | 1.2±0.8 | 1.2±0.9 | 0.0 |
| Uric acid, µmol/L | 882 789 | 312.3±121.7 | 319.3±125.9 | 311.6±121.3 | 6.2 |
| BMI, mg/m2 | 879 415 | 24.0±4.4 | 24.1±4.5 | 24.0±4.4 | 2.2 |
ASD/HL indicates absolute standardized difference/Hodges‐Lehmann; BMI, body mass index; BUN, blood urea nitrogen; INR, international normalized ratio; and MI, myocardial infarction.